- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells ; volume:19 ; number:1 ; day:8 ; month:1 ; year:2019 ; pages:1-8 ; date:12.2019
BMC cancer ; 19, Heft 1 (8.1.2019), 1-8, 12.2019
- Urheber
-
Qiu, Xiaofu
Wang, Wei
Li, Bijun
Cheng, Bo
Lin, Kangjian
Bai, Jian
Li, Huanhui
Yang, Guosheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-5228-2
- URN
-
urn:nbn:de:101:1-2019021123181291720213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qiu, Xiaofu
- Wang, Wei
- Li, Bijun
- Cheng, Bo
- Lin, Kangjian
- Bai, Jian
- Li, Huanhui
- Yang, Guosheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Could we overcome the Winner's Curse by (behavioral) auction design?
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3
Peritumoral Delivery of Docetaxel‐TIPS Microparticles for Prostate Cancer Adjuvant Therapy
Could we overcome the Winner's Curse by (behavioral) auction design?
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3
Peritumoral Delivery of Docetaxel‐TIPS Microparticles for Prostate Cancer Adjuvant Therapy
Could we overcome the Winner's Curse by (behavioral) auction design?
Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer
Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells
Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer
circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3